Mark Wade

10.3k citations

55 papers · 7.5k indexed · 5 hit papers · h-index 31

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 1%
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer

Papers in

Endocrine and Autonomic Systems 7
Cellular and Molecular Neuroscience 16
- Neuroscience and Neuropharmacology Research 12
- Neurotransmitter Receptor Influence on Behavior 11

Co-authors: Geoffrey M. Wahl Yaocheng Li George G. Nomikos Yunyuan V. Wang Adrian Andronache Ivano Legnini Alessandro Fatica Gaia Di Timoteo
Journals: Angiogenesis (3 papers)Nature Communications (2 papers)European Journal of Pharmacology (2 papers)Proceedings of the National Academy of Sciences (2 papers)SLAS DISCOVERY (2 papers)
Partner nations: United States Italy United Kingdom

In The Last Decade

Mark Wade

55 papers receiving 7.4k citations

Hit Papers

5 papers align trajectories log scale

Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis 2017 · 1.7k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Molecular Cell
2013 Nature reviews. Cancer
2013 Cell Metabolism
2010 Nature Medicine
2002 Molecular Cell

Peers

Countries citing papers authored by Mark Wade

Since Specialization

Citations

This map shows the geographic impact of Mark Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wade more than expected).

Fields of papers citing papers by Mark Wade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wade. The network helps show where Mark Wade may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Wade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Wade Line = papers co-authored together Mark Wade links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts Nature Communications ·Laura Curti, Denise Fandel, Nicola Bianchi, Ottavio Croci, Adrian Andronache, Sara Barozzi, Michela Mattioli, Fernanda Ricci, 李慧奇, سامية حساين, Weiping Wan, J PICARD, Camila Schaefer Martins, Nicola Crosetto, Mark Wade, Dario Parazzoli, Stefano Campaner	2024	9
2	Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis Molecular Cell ·Ivano Legnini, Gaia Di Timoteo, Francesca Rossi, Mariangela Morlando, Francesca Briganti, Olga Sthandier, Alessandro Fatica, Tiziana Santini, Adrian Andronache, Mark Wade, Pietro Laneve, Nikolaus Rajewsky, Irene Bozzoni Hit paper breakdown →	2017	1663
3	Multiplex detection of protein–protein interactions using a next generation luciferase reporter Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Lisette G. G. C. Verhoef, Michela Mattioli, Fernanda Ricci, Yaocheng Li, Mark Wade	2015	31
4	Open Access to High-Content Clonogenic Analysis SLAS DISCOVERY ·Fernanda Ricci, Olaf Strandberg, Mark Wade	2014	1
5	Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells Oncogene ·Mark Wade, Paula Gabrielle Veiga Saracchini, Ayumu Matani, Simon M. G. Braun, Francesca Milanesi, Luo Wei Rodewald, Geoffrey M. Wahl	2012	20
6	Modulation of neurotransmitter release in orexin/hypocretin‐2 receptor knockout mice: A microdialysis study Journal of Neuroscience Research ·Jorge E. Ortega, Jason Katner, Richard W. Davis, Mark Wade, Laura Nisenbaum, George G. Nomikos, Kjell Svensson, Kenneth W. Perry	2011	8
7	Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin Nature Medicine ·William L. Holland, Russell Miller, Zhao V. Wang, Kai Sun, Brian M. Barth, Hai H. Bui, Kathryn E. Davis, Benjamin T. Bikman, Nils Halberg, Joseph M. Rutkowski, Mark Wade, María del Pilar Lourdes Guillén Núñez, 達美児島, Joseph T. Brozinick, Bei B. Zhang, Morris J. Birnbaum, Scott A. Summers, Philipp E. Scherer Hit paper breakdown →	2010	730
8	The p53 orchestra: Mdm2 and Mdmx set the tone Trends in Cell Biology ·Mark Wade, Yunyuan V. Wang, Geoffrey M. Wahl	2010	362
9	The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone Nature Neuroscience ·Christelle Gras, Bénédicte Amilhon, Eve M. Lepicard, Odile Poirel, Sidrah Chaudary, Marc Herbin, Sylvie Dumas, Eleni T. Tzavara, Mark Wade, George G. Nomikos, Naı̈ma Hanoun, Françoise Saurini, Marie‐Louise Kemel, 董秋荣, Bruno Giros, Salah El Mestikawy	2008	172
10	Role of metabotropic glutamate receptor 5 in the procholinergic effects of neuropsychotherapeutic compounds Synapse ·Eleni T. Tzavara, Mark Wade, Richard J. Davis, A. R. Thomas, George G. Nomikos	2008	4
11	CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: Role of mGlu5 receptors European Neuropsychopharmacology ·Eleni T. Tzavara, Aldemar Degroot, Mark Wade, Richard J. Davis, George G. Nomikos	2008	20
12	BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death Cell Cycle ·Mark Wade, Luo Wei Rodewald, Joaquı́n M. Espinosa, Geoffrey M. Wahl	2008	18
13	c-Myc, Genome Instability, and Tumorigenesis: The Devil Is in the Details Current topics in microbiology and immunology ·Mark Wade, Geoffrey M. Wahl	2006	61
14	CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action Molecular Pharmacology ·Aldemar Degroot, Attila Köfalvi, Mark Wade, Richard J. Davis, Ricardo J. Rodrigues, Nelson Rebola, Rodrigo A. Cunha, George G. Nomikos	2006	60
15	Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine Psychopharmacology ·Mark Wade, George G. Nomikos	2005	6
16	Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study Brain Research ·Mark Wade, Eleni T. Tzavara, George G. Nomikos	2004	18
17	Effect of Human Angiostatin® Protein on Human Angiogenesis in vitro Angiogenesis ·Хафіз Мікдад Масуд, Shashabilla Ajeng Prayogo, Yi‐Zarn Wang, Mark Wade, Catherine T. Anthony, Conrad A. Hornick, Eugene A. Woltering	2003	8
18	Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice Molecular Psychiatry ·Eleni T. Tzavara, Frank P. Bymaster, Christian C. Felder, Mark Wade, Jesús Gomeza, Jürgen Wess, David L. McKinzie, George G. Nomikos	2003	122
19	Effect of human recombinant Endostatin® protein on human angiogenesis Angiogenesis ·Хафіз Мікдад Масуд, Shashabilla Ajeng Prayogo, Conrad A. Hornick, Yi‐Zarn Wang, Mark Wade, Catherine T. Anthony, Eugene A. Woltering	2002	20
20	Practice patterns in the diagnosis and treatment of erectile dysfunction among family practice physicians Urology ·SCOTT RUTCHIK, L. M. Jakimov, Mark Wade, Greer Sullivan, Walter Rayford, D Pavesi	2001	24

About Mark Wade

Mark Wade is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience, Biophysics, Molecular Biology and Oncology, having authored 55 papers that have together received 7.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (11 papers), Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (8 papers), DNA Repair Mechanisms (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cannabis and Cannabinoid Research (5 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (5.3k citations), Oncology (1.8k citations), Endocrine and Autonomic Systems (337 citations) and Cellular and Molecular Neuroscience (734 citations). Mark Wade has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Geoffrey M. Wahl, Yaocheng Li, George G. Nomikos, Yunyuan V. Wang, Adrian Andronache, Ivano Legnini, Alessandro Fatica, Gaia Di Timoteo, Mariangela Morlando and Francesca Briganti. Their work appears in journals such as Angiogenesis, Nature Communications, European Journal of Pharmacology, Proceedings of the National Academy of Sciences and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact